PetIQ Inc (NASDAQ:PETQ)
| 36.27 Delayed Data As of 4:00pm ET |  -1.21 / -3.23%Today’s Change | 15.83 Today|||52-Week Range 38.99 | -5.67% Year-to-Date |
Latest PETQ News | Press Releases
No recent news for PetIQ Inc.
Today’s Trading
| Previous close | 37.48 |
| Today’s open | 37.42 |
| Day’s range | 36.05 - 37.70 |
| Volume | 23,222 |
| Average volume (3 months) | 304,739 |
| Market cap | $1.1B |
Data as of 4:00pm ET, 01/19/2021
Growth & Valuation
| Earnings growth (last year) | -1,013.66% |
| Earnings growth (this year) | -45.60% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +34.21% |
| P/E ratio | NM |
| Price/Sales | 0.80 |
| Price/Book | 3.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TCRRTCR2 Therapeutics In... | -1.22 | -3.71% |
| KPTIKaryopharm Therapeut... | +0.17 | +1.14% |
| SNDXSyndax Pharmaceutica... | +0.10 | +0.42% |
| ZGNXZogenix Inc | -0.40 | -2.14% |
Data as of 5:46pm ET, 01/19/2021
Financials
| Next reporting date | March 16, 2021 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $709.4M |
| Annual profit (last year) | -$11.5M |
| Net profit margin | -1.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Eagle, Idaho |
Forecasts
